Human neutrophil defensins (alpha-defensins) belong to the family of cationic trisulfide-containing
microbicidal peptides. Besides microbicidal, the peptides exert chemotactic, immunomodulating and
cytotoxic activity and participate in host defense and inflammation. Defensins are important effector
molecules against enveloped viruses, bacteria, fungi and protozoa, and protein concentrations
ranging from 0.5 to 5 μM were shown to kill a wide range of microbes in vitro. Defensins have the
ability to attack susceptible microorganisms and destroy the structure of target cell membranes and.
Several members of each defensin family were shown to act as microbicides against distinct Gramnegative
and Gram-positive bacteria, as well as fungi and viruses in vitro.
Azurophilic granules of neutrophils contain Human Neutrophil Peptide (HNP) 1-4, which are highly
homologous. The three principal human defensins, HNP 1-3, are unique to neutrophils and account
for about 99% of the total defensin content of these cells. Defensins HNP 1-3 are almost exclusively
expressed in neutrophils, therefore it is considered a neutrophil cell marker. Measured amount of
defensins is 3-5 microgram per million human neutrophils. When treated with HNP the outer
membrane of Escherichia coli becomes permeable. This permeabilization furthermore coincided with
the cessation of RNA, DNA and protein synthesis, and with a decreased bacterial viability Defensins
are relatively resistant to proteolysis, low pH and boiling. Activation of neutrophils leads to rapid
release of HNP. HNP can be measured in plasma and other body fluids during infection and
inflammation. In normal plasma very low levels of HNP are present. Activation of polymorphonuclear
leukocytes (PMN) in plasma, as occurs during clotting of blood, leads to a rapid release of HNP.
Anti HNP 1-3 antibody clone D21 recognizes natural HNP 1-3 in biological solutions by means of
ELISA in tissue sections and leukocyte smears fixed with ethanol, methanol/acetone or
paraformaldehyde, in flow cytometry analysis of human neutrophils stained by cell permeabilization
method and in Western-blotting (non-reduced). Furthermore the antibody is cross reactive with
Rhesus monkey and cynomolgous macaques HNP1-3.
Flow cytometry, Frozen sections, Functional studies, Immuno assays, Immuno fluorescence, Immuno precipitation, Paraffin sections, Western blot
F: FCS blocked sections were incubated with D21 antibody 1:500
FC: Cells were fixed and permeabilized, incubation with primary antibody for 30 min.
FS: In vitro:0.5ug/ml, 30min -24h at 37 °C
IF: 1% formaldehyde fixed cells were stained with 5 µl Ab/million cells for 15 min.
P: Formalin fixed sections were deparaffinized and blocked with 1% hydrogen peroxide and serum or 5%BSA
W: Blots blocked with 10% serum for 30'. Primary antibody 2h RT 1:100 in TBS/0.01% tween-20
For immunohistology, flow cytometry and Western blotting dilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:10.